Zoetis Inc. Stock

Equities

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-04-16 pm EDT 5-day change 1st Jan Change
153 USD +2.17% Intraday chart for Zoetis Inc. -8.45% -22.47%
Sales 2024 * 9.17B Sales 2025 * 9.82B Capitalization 68.44B
Net income 2024 * 2.53B Net income 2025 * 2.78B EV / Sales 2024 * 7.94 x
Net Debt 2024 * 4.33B Net Debt 2025 * 3.83B EV / Sales 2025 * 7.36 x
P/E ratio 2024 *
27.4 x
P/E ratio 2025 *
24.6 x
Employees 14,100
Yield 2024 *
1.14%
Yield 2025 *
1.3%
Free-Float 91.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.14%
1 week-9.61%
Current month-11.49%
1 month-13.21%
3 months-24.72%
6 months-14.11%
Current year-24.12%
More quotes
1 week
148.48
Extreme 148.48
164.87
1 month
148.48
Extreme 148.48
174.33
Current year
148.48
Extreme 148.48
200.53
1 year
148.48
Extreme 148.48
201.92
3 years
124.15
Extreme 124.1483
249.27
5 years
90.14
Extreme 90.14
249.27
10 years
28.46
Extreme 28.46
249.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 11-12-31
Director of Finance/CFO 52 21-05-31
Chief Tech/Sci/R&D Officer - 10-12-31
Members of the board TitleAgeSince
Chairman 71 12-12-31
Director/Board Member 73 13-07-31
Director/Board Member 74 13-05-31
More insiders
Date Price Change Volume
24-04-16 153 +2.17% 4,967,562
24-04-15 149.8 -0.14% 8,667,460
24-04-12 150 -7.84% 11,577,753
24-04-11 162.7 -0.29% 2,290,438
24-04-10 163.2 -2.36% 2,666,005

Delayed Quote Nyse, April 15, 2024 at 04:00 pm EDT

More quotes
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
149.8 USD
Average target price
218.3 USD
Spread / Average Target
+45.76%
Consensus